Introduction of New Medicine Delivery Modes is Accelerating the Demand for Live Cell Encapsulation; Global Sales to Reach US$ 430 million by 2031

PUNE, India, July 20, 2021 (GLOBE NEWSWIRE) -- The Global Live Cell Encapsulation Market Share, Trends, Analysis and Forecasts, 2021-2031 provides insights on key developments, business strategies, research & development activities, supply chain analysis, competitive landscape, and market composition analysis.

Live cell encapsulation market size was estimated to be US$ 290 million in 2020 and is expected to reach US$ 430 million by 2031 at a CAGR of 3.7%. Live Cell Encapsulation alludes to a methodology for treating discrete diseases. Live cell encapsulation technology epitomizes the live cells in defensive biocompatible capsules. The blood and supplements are permitted to enter the capsules and subsequently takes care of sustained live cells inside them. The capsules shield the live cells from obliteration by the safe arrangement of the body cells.

The epitomized cells are delivered at a controlled rate inside the patient's body. Besides, such cells are utilized for directing in-vivo concentrates without influencing the host genome. BioTime, Inc. (US) ruled the live cell encapsulation market during 2020. The organization has a solid geographic presence across the provinces like US, Australia, New Zealand, Israel, Canada, China, Japan, and Taiwan. BioTime, Inc. essentially is fixated around item commercialization to additionally reinforce its position in the live cell encapsulation market. In accordance with this, the organization popularized pluripotent cells for research, drug making, and Regenerative Medication treatments.

View the Entire report with Table of Contents:

Growth driving factors of Global Live Cell Encapsulation Market

The Live Cell Encapsulation Market is expected to alter during the forecast period 2021-2031 attributable to driving factors like expanding public-private collaborative ventures to assist item betterment, rising research to build up the clinical quality of cell encapsulation inventions and rising public attentiveness identified with the clinical part of epitomized cells in disease mitigation.

However, restricted accessibility of excellent crude material and the preference given to alternative treatments are relied upon to block the market growth during the estimation period. Various factors, namely, an undeniable degree of research exercises in live cell encapsulation innovations and the rising attentiveness programs in different nations worldwide are expected to fuel the growth of the market.

Also, the thriving speculations by different public and private medical and health care associations have made a pathway for some organizations to put resources into giving new encapsulation methods, prompting the general growth of the market. Moreover, the tendency towards novel medication delivery models for disease treatment is anticipated to power the growth of the market during 2021-2031. In any case, the absence of experts, moral along with lawfully begotten issues, and exorbitance of different limited scope organizations to enter the market because of high item producing costs are relied upon to check the growth of live cell encapsulation market.

In addition, the accessibility of excellent crude material is additionally limiting the growth of the market.

Access Sample Pages of this Report:

The leading market segments of Global Live Cell Encapsulation Market

Cell encapsulation is employed procedure for the assembling of tablets, capsules, and dose structures for compelling medication administration. The growth of this section incorporates the expanding reception of cell encapsulation for drug delivery is fundamentally because of its procedural advantages namely, improved viability, decreased hazardous effects, and improved patient condition post procedure.

The market in the Americas is postulated to dominate the worldwide live cell encapsulation market during the forecast period 2021-2031. Attributable to the expanding per capita medical services consumption post corona virus outbreak since 2020, and the substantial acceptance of new technology in the area. Europe is relied upon to stand firm on the second sizable position in the worldwide live cell encapsulation market. The market growth in this province is a direct result of the presence of a reasoned medical care system and rise in cases registered with perilous diseases since past few years.

For example, as per cancer research UK, there were around 14,957 instances of cases registered in 2019. Such high paces of cancerous growth are probably going to build demand for the utilization of new effective methods, for example, encapsulation just as an increase in the market demand for cellular research.

These factors are expected to decidedly affect the live cell encapsulation market for coming years.

North America is expected to lead the worldwide market, assigned to ascend in clinical information and data about the adequacy of cell encapsulation strategy and elaboration in selection of cell encapsulation methods by clinical experts. Also, alluvion in research exercises identified with cell encapsulation and ascend in public as well as private demand in medical services is anticipated to drive the live cell encapsulation market in North America province.

Related report:

Global Embolic Protection Devices Market:   

Global Dermatology Lasers Market:   

Global Multiple Myeloma Market:

Asia-Pacific is assessed to be the quickest developing province in the market because of the tremendous patient pool of ongoing diseases and government drives of medical services changes. The market in the Center East and Africa is probably going to represent the littlest portion of the worldwide live cell encapsulation market during 2021-2031.

The market growth in this area owes to the low extra cash available for medical and health care sector in the province.

The key players of the Global Live Cell Encapsulation Market are:

BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) Sigilon Therapeutics, Inc. (US), Evonik (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), and others.

Buy This Report:

Global Live Cell Encapsulation Market Key Segments:

By Manufacturing Technique type

  • Simple Dripping
  • Electrostatic Dripping
  • Liquid Jet Break Up
  • Coaxial Airflow
  • Vibrating Jet
  • Jet Cutting
  • Rotating Disk Atomization
  • Others

By Polymer type

  • Alginate
  • Chitosan
  • Siliceous Encapsulates
  • Cellulose Sulfate
  • Other Polymers

By Application type

  • Drug Delivery
  • Regenerative medicine
  • Cell Transplantation
  • Probiotics
  • Research
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of APAC
  • Middle East & Africa
    • UAE
    • South Africa
    • Saudi Arabia
    • Rest of MEA
  • South America
    • Brazil
    • Rest of South America

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact Us:



Phone (USA): +1 707 736 6633

Email address: